Pessary Treatment Successful for Symptomatic Pelvic Organ Prolapse
WEDNESDAY, Feb. 24, 2021 -- About three-quarters of patients with symptomatic pelvic organ prolapse (POP) report successful pessary treatment at five-year follow-up, according to a study published online Feb. 24 in Menopause.
Congcong Ma, Ph.D., from the Peking Union Medical College Hospital in Beijing, and colleagues conducted a prospective observational study involving 312 women with symptomatic POP who received pessary treatment between November 2013 and July 2015. Patients were initially fitted with a ring pessary with support, and those who failed were fitted with a Gellhorn pessary. For five years, 265 patients with successful pessary fitting were followed.
The researchers found that 180 of 239 patients continued pessary use after five years (75.3 percent continuation rate) and 26 were lost to follow-up. Over time, there was a decrease in discontinuation rates, from 8.7 to 2.7 percent at one and five years, respectively. Potential discontinuation risk factors included total vaginal length <7.5 cm, improvement in Urinary Impact Questionnaire-7 scores <50 percent at three months, and incapability of self-care (odds ratios, 2.7, 2.1, and 2.6, respectively).
"The vaginal pessary is an effective treatment in patients with symptomatic POP, with a high continuation rate and minor complications," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
WEDNESDAY, April 7, 2021 -- Arkansas on Tuesday became the first state to ban gender-confirming treatments and surgery for transgender youth, but opponents say they will take...
TUESDAY, March 30, 2021 -- Self-reported data via text messaging revealed that patients did not use about 60 percent of prescribed opioid tablets following common orthopedic or...
FRIDAY, Jan. 15, 2021 -- After publication of the 2012 guidelines defining vasectomy success as either azoospermia or rare nonmotile sperm, men undergoing vasectomy had a lower...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.